Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors. PMID: 35338084 Journal: Journal for ImmunoTherapy of Cancer Year: 2022 Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255. Impact factor: 13.751 Publication type: Paper in international publication Authors: Vidal, Noemi, Garcia-Carbonero, Rocio, Bazan-Peregrino, Miriam, Gil-Martin, Marta, Alvarez, Rafael, Macarulla, Teresa, Riesco-Martinez, Maria C, Verdaguer, Helena, Guillen-Ponce, Carmen, Farrera-Sal, Marti et al. DOI: 10.1136/jitc-2021-003255 Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors. PMID: 35338084 Journal: Journal for ImmunoTherapy of Cancer Year: 2022 Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255. Impact factor: Publication type: Paper in international publication Authors: Alemany, Ramon; Alvarez, Rafael; Bazan-Peregrino, Miriam; Blasco, Carmen; Blasi, Emma; Capella, Gabriel; Cascallo, Manel; Costa, Marcel; Del Pozo, Natalia; Farrera-Sal, Marti et al. DOI: 10.1136/jitc-2021-003255 Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas. PMID: 35815644 Journal: Future Oncology Year: 2022 Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11. Impact factor: 3.404 Publication type: Review in international publication Authors: Studeny, Matus, Liu, Meiruo, Hamed, Zohra Oum', Morgensztern, Daniel, Kuboki, Yasutoshi, Gambardella, Valentina, Felip, Enriqueta, Wermke, Martin, Owonikoko, Taofeek K et al. DOI: 10.2217/fon-2022-0196 Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas. PMID: 35815644 Journal: Future Oncology Year: 2022 Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11. Impact factor: Publication type: Review in international publication Authors: Felip, Enriqueta; Gambardella, Valentina; Hamed, Zohra Oum'; Kuboki, Yasutoshi; Liu, Meiruo; Morgensztern, Daniel; Owonikoko, Taofeek K; Studeny, Matus; Wermke, Martin et al. DOI: 10.2217/fon-2022-0196 Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer. PMID: 35298959 Journal: LUNG CANCER Year: 2022 Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1. Impact factor: 5.705 Publication type: Paper in international publication Authors: Santoro, Armando, Su, Wu-Chou, Simonelli, Matteo, Ch Yang, James, Ardizzoni, Andrea, Barlesi, Fabrice, Hyoung Kang, Jin, DiDominick, Sarah, Abdelhady, Ahmed, Chen, Xueying et al. DOI: 10.1016/j.lungcan.2022.02.010 Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer. PMID: 35298959 Journal: LUNG CANCER Year: 2022 Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1. Impact factor: Publication type: Paper in international publication Authors: Abdelhady, Ahmed; Ardizzoni, Andrea; Barlesi, Fabrice; Ch Yang, James; Chen, Xueying; DiDominick, Sarah; Felip, Enriqueta; Hyoung Kang, Jin; Navarro, Alejandro; Santoro, Armando et al. DOI: 10.1016/j.lungcan.2022.02.010 Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers. PMID: 35305400 Journal: ESMO Open Year: 2022 Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16. Impact factor: 6.54 Publication type: Paper in international publication Authors: Tabernero, J, Andre, F, Blay, J-Y, Bustillos, A, Fear, S, Ganta, S, Jaeger, D, Maio, M, Mileshkin, L, Melero, I et al. DOI: 10.1016/j.esmoop.2022.100419 Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers. PMID: 35305400 Journal: ESMO Open Year: 2022 Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16. Impact factor: Publication type: Paper in international publication Authors: Andre, F; Blay, J-Y; Bustillos, A; Fear, S; Ganta, S; Jaeger, D; Maio, M; Melero, I; Mileshkin, L; Tabernero, J et al. DOI: 10.1016/j.esmoop.2022.100419 Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO). PMID: 35257949 Journal: LUNG CANCER Year: 2022 Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3. Impact factor: 5.705 Publication type: Paper in international publication Authors: Ozguroglu, Mustafa, Rodriguez Abreu, Delvys, Adeniji, Abidemi, Lorence, Robert M, Voccia, Isabelle, Chisamore, Michael J, Riess, Jonathan W, Molinier, Olivier, Madelaine, Jeannick, Kim, Sang-We et al. DOI: 10.1016/j.lungcan.2022.01.023 Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO). PMID: 35257949 Journal: LUNG CANCER Year: 2022 Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3. Impact factor: Publication type: Paper in international publication Authors: Adeniji, Abidemi; Barlesi, Fabrice; Bennouna, Jaafar; Chisamore, Michael J; Erman, Mustafa; Felip, Enriqueta; Isla, Dolores; Kim, Sang-We; Levy, Benjamin; Lorence, Robert M et al. DOI: 10.1016/j.lungcan.2022.01.023 Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer. PMID: 35912190 Journal: Frontiers in Oncology Year: 2022 Reference: Front Oncol. 2022 Jul 14;12:891886. doi: 10.3389/fonc.2022.891886. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Gomez-Iturriaga, Alfonso; Hervas-Moron, Asuncion; Lara, Pedro C; Lozano, Antonio; Maldonado, Xavier; Palacios-Eito, Amalia; Rodriguez-Melcon, Juan I; Sancho, Gemma; Villafranca, Elena et al. DOI: 10.3389/fonc.2022.891886 Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. PMID: 35217575 Journal: Journal for ImmunoTherapy of Cancer Year: 2022 Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776. Impact factor: 13.751 Publication type: Paper in international publication Authors: Carvajal, Richard D, Kyi, Chrisann, Esaki, Taito, Prawira, Amy, Akerley, Wallace, De Braud, Filippo, Hui, Rina, Zhang, Tian, Soo, Ross A, Maur, Michela et al. DOI: 10.1136/jitc-2021-003776 Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. PMID: 35217575 Journal: Journal for ImmunoTherapy of Cancer Year: 2022 Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776. Impact factor: Publication type: Paper in international publication Authors: Akerley, Wallace; Askoxylakis, Vasileios; Carion, Ana; Carvajal, Richard D; Chowdhury, Niladri Roy; De Braud, Filippo; Deschler-Baier, Barbara; Esaki, Taito; Gusenleitner, Daniel; Hong, David S et al. DOI: 10.1136/jitc-2021-003776 Phenotypes of idiopathic pulmonary arterial hypertension. PMID: 36179740 Journal: Lancet Respiratory Medicine Year: 2022 Reference: Lancet Respir Med. 2022 Oct;10(10):e87. doi: 10.1016/S2213-2600(22)00290-9. Impact factor: Publication type: Letter or abstract Authors: Cruz-Utrilla, Alejandro; Escribano-Subias, Pilar; Lopez-Meseguer, Manuel; Martinez-Menaca, Amaya; Perez-Olivares, Carmen et al. DOI: 10.1016/S2213-2600(22)00290-9 Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT. PMID: 35055345 Journal: Journal of Personalized Medicine Year: 2022 Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030. Impact factor: 4.945 Publication type: Paper in international publication Authors: Herance, Jose Raul, Simo, Rafael, Velasquez, Mayra Alejandra, Paun, Bruno, Garcia-Leon, Daniel, Aparicio, Carolina, Mares, Roso, Simo-Servat, Olga, Castell-Conesa, Joan, Hernandez, Cristina et al. DOI: 10.3390/jpm12010030 Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT. PMID: 35055345 Journal: Journal of Personalized Medicine Year: 2022 Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030. Impact factor: Publication type: Paper in international publication Authors: Aguade-Bruix, Santiago; Aparicio, Carolina; Castell-Conesa, Joan; Garcia-Leon, Daniel; Herance, Jose Raul; Hernandez, Cristina; Mares, Roso; Paun, Bruno; Simo, Rafael; Simo-Servat, Olga et al. DOI: 10.3390/jpm12010030 Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A. PMID: 36477027 Journal: Nature Communications Year: 2022 Reference: Nat Commun. 2022 Dec 7;13(1):7529. doi: 10.1038/s41467-022-35065-z. Impact factor: Publication type: Paper in international publication Authors: Apala, J V; Bueno, M J; Caleiras, E; Calvo, I; Cejalvo, J M; Colomer, R; Cortes, J; Fustero-Torre, C; Garcia-Saenz, J A; Gil-Gil, M et al. DOI: 10.1038/s41467-022-35065-z Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention. PMID: 35635535 Journal: LIVER INTERNATIONAL Year: 2022 Reference: Liver Int. 2022 May 30. doi: 10.1111/liv.15327. Impact factor: 5.828 Publication type: Paper in international publication Authors: Martro, Elisa, Ouaarab, Hakima, Saludes, Veronica, Buti, Maria, Trevino, Begona, Roade, Luisa, Egea-Cortes, Laia, Reyes-Urena, Juliana, Not, Anna, Majo, Xavier et al. DOI: 10.1111/liv.15327 Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention. PMID: 35635535 Journal: LIVER INTERNATIONAL Year: 2022 Reference: Liver Int. 2022 Aug;42(8):1751-1761. doi: 10.1111/liv.15327. Epub 2022 Jun 14. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Colom, Joan; Egea-Cortes, Laia; Gomez I Prat, Jordi; Majo, Xavier; Martro, Elisa; Not, Anna; Ouaarab, Hakima; Reyes-Urena, Juliana; Roade, Luisa et al. DOI: 10.1111/liv.15327 Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung. PMID: 35312541 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2022 Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4. Impact factor: 4.872 Publication type: Paper in national publication Authors: Cruz, Maria Jesus; Millon, Laurence; Villar, Ana; Reboux, Gabriel; Morell, Ferran; Rouzet, Adeline et al. DOI: 10.1016/j.arbres.2021.02.011 Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung. PMID: 35312541 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2022 Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4. Impact factor: Publication type: Paper in national publication Authors: Cruz, Maria Jesus; Millon, Laurence; Morell, Ferran; Reboux, Gabriel; Rouzet, Adeline; Villar, Ana et al. DOI: 10.1016/j.arbres.2021.02.011 Pineal germinoma in a young adult: A case report. PMID: 35347869 Journal: Cancer reports (Hoboken, N.J.) Year: 2022 Reference: Cancer Rep (Hoboken). 2022 Mar 28:e1611. doi: 10.1002/cnr2.1611. Impact factor: 0 Publication type: Letter or abstract Authors: Fernandez-Rodriguez, Lissett Jeanette, Maldonado-Pijoan, Xavier et al. DOI: 10.1002/cnr2.1611 Pineal germinoma in a young adult: A case report. PMID: 35347869 Journal: Cancer reports (Hoboken, N.J.) Year: 2022 Reference: Cancer Rep (Hoboken). 2022 Sep;5(9):e1611. doi: 10.1002/cnr2.1611. Epub 2022 Mar 28. Impact factor: Publication type: Letter or abstract Authors: Fernandez-Rodriguez, Lissett Jeanette; Maldonado-Pijoan, Xavier et al. DOI: 10.1002/cnr2.1611 PirePred: An Accurate Online Consensus Tool to Interpret Newborn Screening Related Genetic Variants in Structural Context. PMID: 35143952 Journal: JOURNAL OF MOLECULAR DIAGNOSTICS Year: 2022 Reference: J Mol Diagn. 2022 Apr;24(4):406-425. doi: 10.1016/j.jmoldx.2022.01.005. Epub 2022 Feb 7. Impact factor: 5.568 Publication type: Paper in international publication Authors: Galano-Frutos, Juan Jose; Garcia-Cebollada, Helena; Lopez, Alfonso; Rosell, Mireia; Cruz, Xavier de la; Fernandez-Recio, Juan; Sancho, Javier et al. DOI: 10.1016/j.jmoldx.2022.01.005 Pagination First page « First Previous page ‹ Previous … Page 238 Page 239 Page 240 Page 241 Current page 242 Page 243 Page 244 Page 245 Page 246 … Next page Next › Last page Last »